ESR1 rs1122821: Reproductive Traits & Menopause Timing
The rs1122821 variant is a common single nucleotide polymorphism located within the estrogen receptor 1 (ESR1) gene on chromosome 6. Genetic studies have linked this variant to modest variations in circulating estradiol levels, ovulatory response, and the timing of natural menopause. It represents a subtle, non-diagnostic modulator of endocrine physiology rather than a direct cause of disease.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| TT | Carriers of the homozygous TT genotype carry two copies of the common baseline allele. In population research, this profile is generally associated with standard population-average baseline estradiol levels and typical reproductive aging trajectories. It does not confer an elevated or reduced clinical likelihood of early menopause on its own. | Informational |
| CT | Heterozygous CT individuals possess one copy of the C allele and one copy of the T allele. Cohort studies observe modest intermediate variations in circulating estradiol concentrations and ovarian response relative to homozygous genotypes. This single copy creates subtle statistical differences in trait averages across large groups but has negligible standalone clinical significance for an individual. | Informational |
| CC | Homozygous CC individuals carry two copies of the minor allele linked in research cohorts to altered estradiol sensitivity, variation in ovulatory follicular dynamics, and modest differences in the timing of natural menopause. While statistically significant across population studies, carrying this genotype is not diagnostic of any endocrine disorder or premature ovarian insufficiency. | Higher attention |
Genetic Architecture and Location
The single nucleotide polymorphism rs1122821 resides within the estrogen receptor 1 (ESR1) gene locus on the long arm of chromosome 6 (6q25.1). In the human genome, this position reflects a single-base variation between thymine (T) and cytosine (C). Rather than directly altering the amino acid sequence of the resulting protein, rs1122821 is an intronic or regulatory variation commonly cataloged across standard human genome assemblies. Variants in this genomic segment frequently function as expression modulators or serve as proxy markers that correlate strongly with extended haplotype blocks across the ESR1 locus. Large genomic repositories like dbSNP and Ensembl maintain this position as a common marker used to interrogate polygenic traits related to sex hormone metabolism and reproductive longevity.
Biological Role of the ESR1 Gene
The ESR1 gene provides instructions for producing estrogen receptor alpha (ER-alpha), a nuclear ligand-activated transcription factor that mediates the cellular actions of estrogenic hormones, particularly 17-beta-estradiol. Upon hormone binding, ER-alpha dimerizes and translocates into the cell nucleus, where it binds directly to estrogen response elements in genomic DNA to activate or repress downstream target genes. As highlighted by resources like MedlinePlus Genetics and the NIH Genetic Testing Registry, ER-alpha plays fundamental roles in sexual development, gestation, reproductive tract maintenance, bone mineral homeostasis, and cardiovascular tissue signaling. Because ER-alpha is an indispensable conductor of endocrine signaling across the human lifespan, small inherited changes in its expression or transcriptional efficiency can produce downstream shifts in hormonal sensitivity and reproductive physiology.
Associated Traits and Evidence Strength
Genome-wide association studies and endocrine candidate-gene cohorts have linked ESR1 variants, including rs1122821, to subtle shifts in endocrine and reproductive traits. Published investigations associate the variant with variations in circulating baseline estradiol, ovarian follicular dynamics during assisted reproduction, and modest shifts in the age at natural menopause. Across reproductive cohorts, differences in natural menopause timing associated with single common ESR1 alleles generally range within a few months to approximately one year rather than causing abrupt premature ovarian failure. The scientific consensus ranks this evidence as moderate. While statistical associations consistently appear in population-scale studies, the effect sizes for individual variants like rs1122821 are modest, and outcomes are shaped by broad polygenic backgrounds and environmental influences.
Ancestral Diversity and Allele Distribution
The frequency of rs1122821 exhibits significant variation across global populations, reflecting distinct regional genetic ancestries. In cohorts of European descent, the minor allele displays a frequency of approximately 0.35, meaning that roughly one in three alleles in the general population carries the variant. In East Asian populations, the minor allele frequency is somewhat lower, resting near 0.20 according to global genomic reference databases like gnomAD and the 1000 Genomes Project. Because background linkage disequilibrium patterns differ between ancestral groups, the precise biological tag that rs1122821 represents may correlate with slightly different downstream genomic markers in different geographic lineages. Consequently, researchers caution against directly extrapolating statistical effect sizes observed in one ancestral group to another without dedicated multi-ancestry replication.
Clinical Utility and Lifestyle Context
Direct-to-consumer genetic testing may report a person's genotype at rs1122821, but this variant is strictly educational and non-diagnostic. Having one or two copies of a specific allele does not predict clinical conditions such as infertility, early menopause, or hormonal disorders with clinical certainty. The timing of menopause and hormone concentrations are multifactorial traits heavily governed by non-genetic factors—including smoking history, nutritional health, overall body mass, and age—alongside hundreds of other genetic variants. Readers should never alter prescription hormone regimens, fertility therapies, or reproductive plans based on this single marker. Anyone with questions regarding ovarian function, fertility treatments, or hormone therapy dosing should seek personalized guidance from a physician, reproductive endocrinologist, or pharmacist.
How common is this variant?
The minor allele occurs at an estimated frequency of approximately 0.35 in populations of European ancestry and roughly 0.20 in East Asian cohorts, with homozygous genotypes being widespread and common globally.
Frequently asked questions
Does carrying the rs1122821 variant mean I will experience early menopause?
No, carrying this variant does not mean you will enter early menopause. While statistical studies link ESR1 variants to modest shifts in the average age of natural menopause, the actual difference observed is usually less than a year. Menopause timing is a complex trait determined by hundreds of genes, lifestyle habits such as smoking, and general physical health.
Can this ESR1 variant diagnose estrogen resistance or infertility?
No, rs1122821 cannot diagnose estrogen resistance, infertility, or any other hormonal disease. Severe clinical syndromes of estrogen resistance stem from rare, high-impact pathogenic mutations in ESR1, whereas rs1122821 is a common, benign variant that slightly shifts population averages without causing monogenic disease.
Should I change my hormone replacement therapy or birth control based on this result?
You should never change the dosage, type, or schedule of your hormone medications based on an individual genetic variant like rs1122821. Clinical guidelines do not recommend altering therapy or dosing from this SNP alone. Discuss any concerns about hormone therapy safety or effectiveness directly with your healthcare provider or pharmacist.
Why do allele frequencies for rs1122821 vary between different ancestries?
Allele frequency differences between European, East Asian, and other ancestral populations are normal results of human evolutionary history, genetic drift, and geographic isolation. Because gene architecture varies across ancestries, the presence of this variant may reflect slightly different linked genomic regions depending on a person's genetic background.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1122821?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29